Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2009-08-04
2011-12-27
Kemmerer, Elizabeth C (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S017700, C530S350000, C530S300000, C424S570000, C435S368000
Reexamination Certificate
active
08084425
ABSTRACT:
In general, the invention features substantially purified MANF and substantially purified nucleic acids encoding the same. The invention also features a pharmaceutical composition that includes MANF and a pharmaceutically-acceptable excipient, methods for treatment of a neurodegenerative disease, methods for improving dopaminergic neuronal survival during or following cell transplantation, methods for production of neurons for transplantation, and methods for identifying compounds that modulate or mimic MANF's biological activity.
REFERENCES:
patent: 2004/0006780 (2004-01-01), Gerber et al.
Petrova PS et al. MANF, A new mesencephalic, Astrocyte—derived neurotrophic factor with selectivity for dopaminergic neurons. J Mol Neurosci. 2003; 20(2):173-188.
Shridhar V et al. A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas. Oncogen, 1996; 12(9):1931-9. Abstract Only.
Commissiong John W.
Raibekas Andrei A.
Ballard Kimberly A
Kemmerer Elizabeth C
Wilson Sonsini Goodrich & Rosati
LandOfFree
Dopaminergic neuronal survival-promoting factors and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dopaminergic neuronal survival-promoting factors and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopaminergic neuronal survival-promoting factors and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4269793